Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOCUSATE Cause Product use in unapproved indication? 142 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 142 reports of Product use in unapproved indication have been filed in association with DOCUSATE (SENNA-S). This represents 5.4% of all adverse event reports for DOCUSATE.

142
Reports of Product use in unapproved indication with DOCUSATE
5.4%
of all DOCUSATE reports
50
Deaths
91
Hospitalizations

How Dangerous Is Product use in unapproved indication From DOCUSATE?

Of the 142 reports, 50 (35.2%) resulted in death, 91 (64.1%) required hospitalization, and 83 (58.5%) were considered life-threatening.

Is Product use in unapproved indication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOCUSATE. However, 142 reports have been filed with the FAERS database.

What Other Side Effects Does DOCUSATE Cause?

Somnolence (514) Gastrooesophageal reflux disease (419) Pneumonia aspiration (341) Coma (337) Constipation (329) Drug ineffective (288) Dyspnoea (277) Off label use (236) Vomiting (207) Pain (195)

What Other Drugs Cause Product use in unapproved indication?

DUPILUMAB (33,452) DICLOFENAC (12,197) METHOTREXATE (8,930) PREDNISONE (7,625) RITUXIMAB (7,519) MYCOPHENOLATE MOFETIL (5,910) ACETAMINOPHEN (5,819) CYCLOPHOSPHAMIDE (5,750) RISPERIDONE (5,551) TACROLIMUS (5,057)

Which DOCUSATE Alternatives Have Lower Product use in unapproved indication Risk?

DOCUSATE vs DOCUSATE\SENNOSIDES DOCUSATE vs DOCUSATE\SENNOSIDES A AND B DOCUSATE vs DOFETILIDE DOCUSATE vs DOLUTEGRAVIR DOCUSATE vs DOLUTEGRAVIR\LAMIVUDINE

Related Pages

DOCUSATE Full Profile All Product use in unapproved indication Reports All Drugs Causing Product use in unapproved indication DOCUSATE Demographics